Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice

Journal of Clinical Virology

Volumn 13, Issue 1-2, 1999, Pages 17-27

  Operschall, Elisabeth ^a   Schuh, Theda ^a   Heinzerling, Lucie ^a   Pavlovic, Jovan ^a   Moelling, Karin ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cytokines; DNA vaccine; GM CSF; IL 12; Influenza A virus; La Crosse virus

Indexed keywords

CYTOKINE; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; PLASMID DNA; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; INFLUENZA VIRUS A; LA CROSSE VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VACCINATION; VIRUS INFECTION; WEIGHT REDUCTION;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CRICETINAE; DNA, VIRAL; ENCEPHALITIS, CALIFORNIA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-12; LA CROSSE VIRUS; MICE; MICE, INBRED C57BL; NUCLEOCAPSID PROTEINS; PLASMIDS; VACCINES, DNA;

EID: 0032988304     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(99)00008-6     Document Type: Conference Paper

References (47)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med. 3:1997;526-532.
3. Cardoso A.I., Blixenkrone M.M., Fayolle J., Liu M., Buckland R., Wild T.F. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology. 225:1996;293-299.
4. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.A., Wolf S.F., Young D., Clark S.C., Trinchieri G. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med. 173:1991;869-879.
5. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., Tao M.H. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol. 160:1998;1320-1329.
6. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 186:1997;1623-1631.
7. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med. 1:1995;583-587.
8. Donnelly J.J., Ulmer J.B., Liu M.A. DNA vaccines. Life Sci. 60:1997;163-172.
9. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 158:1997;2278-2284.
10. Gazzinelli R.T., Giese N.A., Morse H.R. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med. 180:1994;2199-2208.
11. Geissler M., Gesien A., Tokushige K., Wands J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol. 158:1997;1231-1237.
12. Hassett D.E., Whitton J.L. DNA immunization. Trends Microbiol. 4:1996;307-312.
13. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med. 177:1993;1505-1509.
14. Hendrzak J.A., Brunda M.J. Antitumor and antimetastatic activity of interleukin-12. Curr. Top. Microbiol. Immunol. 213:1996;65-83.
15. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol. 158:1997;4591-4601.
16. Kim J.J., Weiner D.B. DNA gene vaccination for HIV. Springer Semin Immunopathol. 19:1997;175-194.
17. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 158:1997;816-826.
18. Kim J.J., Nottingham L.K., Wilson D.M., Bagarazzi M.L., Tsai A., Morrison L.D., Javadian A., Chalian A.A., Agadjanyan M.G., Weiner D.B. Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine. 16:1998;1828-1835.
19. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects: on human lymphocytes. J Exp Med. 170:1989;827-845.
20. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol. 71:1997;3138-3145.
21. Lin Y.L., Chen L.K., Liao C.L., Yeh C.T., Ma S.H., Chen J.L., Huang Y.L., Chen S.S., Chiang H.Y. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol. 72:1998;191-200.
22. Manickan E., Yu Z., Rouse R.J., Wire W.S., Rouse B.T. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunol. 8:1995;53-61.
23. McClements W.L., Amnstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA. 93:1996;11414-11420.
24. McDonnell W.M., Askari F.K. DNA vaccines. New Engl J Med. 334:1996;42-55.
25. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science. 229:1985;16-22.
26. Metzger D.W., Buchanan J.M., Collins J.T., Lester T.L., Murray K.S., Van C.V., Vogel L.A., Dunnick W.A. Enhancement of humoral immunity by interleukin-12. Ann New York Acad Sci. 795:1996;100-115.
27. Moelling K. DNA for genetic vaccination and therapy. Cytokines Cell Mol Ther. 3:1997;127-135.
28. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., Ulmer J.B., Donnelly J.J., Liu M.A. Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol. 12:1993;777-783.
29. Mosmann T.R., Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 46:1989;111-147.
30. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type 11 interferons in antiviral defence. Science. 264:1994;1918-1921.
31. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cellmediated immune responses against HIV-1 antigens. J Immunol. 159:1997;3638-3647.
32. Pavlovic J, Petrzilka D, Operschall E, Moelling K. Protection against influenza A virus by DNA vaccination depends on the humoral response and dose of challenge virus. 1999a: submitted.
33. + T cells. 1999b: submitted.
34. Schultz J., Pavlovic J, Strack B., Nawrath M., Moelling K. Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum. Gene Ther. 10:1999;407-417.
35. Stern A.S., Podlaski F.J., Hulmes J.D., Pan Y.C., Quinn P.M., Wolitzky A.G., Familletti P.C., Stremlo D.L, Truitt T., Chizzonite R. et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA. 87:1990;6808-6812.
36. Tarr P.E. Granulocyte-macrophage colony-stimulating factor and the immune system. Med Oncol. 13:1996;133-140.
37. Thompson W.H., Anslow R.O., Hanson R.P., Defoliart G.R. La Crosse virus isolations from mosquitoes in Wisconsin, 1964-68. Am J Trop Med Hyg. 21:1972;90-96.
38. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
39. Tsuji T., Hamajima K., Fukushima J., Xin K.Q., Ishii N., Aoki I., Ishigatsubo Y., Tani K., Kawamoto S., Nitta Y., Miyazaki J., Koff W.C., Okubo T., Okuda K. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol. 158:1997;4008-4013.
40. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
41. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A.I., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
42. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol. 154:1995;4701-4709.
43. Xiang Z., Ertl H.C. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135.
44. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
45. Xiang Z.Q., Knowles B.B., McCarrick J.W., Ertl H.C. Immune effector mechanisms required for protection to rabies virus. Virology. 214:1995;398-404.
46. Xu L., Sanchez A., Yang Z., Zaki S.R., Nabel E.G., Nichol S.T., Nabel G.J. Immunization for Ebola virus infection. Nat Med. 4:1998;37-42.
47. Yang K., Mustafa F., Valsamakis A., Santoro J.C., Griffin D.E., Robinson H.L. Early studies on DNA-based immunizations for measles virus. Vaccine. 15:1997;888-891.